467 (Rizatriptan Benzoate (Orally Disintegrating) 5 mg (base))
Pill with imprint 467 is White, Round and has been identified as Rizatriptan benzoate (orally disintegrating) 5 mg (base). It is supplied by Glenmark Generics Inc., USA.
Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for 467
Rizatriptan benzoate (orally disintegrating)
- Imprint:
- 467
- Strength:
- 5 mg (base)
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Glenmark Generics Inc., USA
- National Drug Code (NDC):
- 68462-0467
More about rizatriptan
- Rizatriptan Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 230 Reviews – Add your own review/rating
- Drug class: antimigraine agents
Consumer resources
- Rizatriptan
- Rizatriptan Orally Disintegrating Tablets
- Rizatriptan Tablets
- Rizatriptan (Advanced Reading)
Other brands: Maxalt, Maxalt-MLT
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
